Norihisa Ishimura Selected Research

midkine receptors

10/2006

Increased expression of midkine in the rat colon during healing of experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norihisa Ishimura Research Topics

Disease

10	Gastroesophageal Reflux (GERD) 01/2022 - 12/2008
10	Eosinophilic Esophagitis 01/2021 - 01/2012
10	Barrett Esophagus (Barrett's Esophagus) 03/2016 - 01/2004
9	Neoplasms (Cancer) 05/2022 - 01/2004
7	Inflammation (Inflammations) 01/2021 - 05/2005
6	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2018 - 08/2013
5	Colitis 05/2022 - 04/2003
5	Peptic Esophagitis (Reflux Esophagitis) 01/2022 - 06/2007
5	Infections 02/2021 - 04/2003
4	Pathologic Constriction (Stenosis) 07/2021 - 01/2018
4	Eosinophilia 05/2018 - 01/2017
4	Hiatal Hernia 03/2017 - 08/2006
4	Carcinogenesis 09/2011 - 07/2004
3	Dyspepsia (Indigestion) 04/2018 - 01/2009
3	Eosinophilic enteropathy 01/2018 - 01/2012
3	Hypersensitivity (Allergy) 01/2018 - 08/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 04/2015
2	Pancreatitis 05/2022 - 06/2006
2	Gastritis 06/2021 - 07/2004
2	Non-alcoholic Fatty Liver Disease 03/2021 - 01/2018
2	Body Weight (Weight, Body) 03/2021 - 07/2011
2	Celiac Disease (Celiac Sprue) 08/2020 - 02/2018
2	Autoimmune enteropathy 08/2020 - 02/2018
2	Atrophy 07/2020 - 03/2017
2	Ulcer 04/2018 - 10/2011
2	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 07/2006
2	Diverticulum 04/2017 - 10/2016
2	Gastroenteritis 01/2016 - 01/2012
2	Bile Reflux 06/2012 - 09/2011
2	Hypoxia (Hypoxemia) 02/2012 - 12/2008
2	Chronic Hepatitis C 01/2010 - 01/2003
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2006 - 04/2003
2	Cholangiocarcinoma 01/2006 - 05/2005
1	Ascites 11/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 11/2022
1	Portal Hypertension 11/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2022
1	Ulcerative Colitis 05/2022
1	Hyperplasia 04/2022
1	Non-Erosive Reflux Disease 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 06/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2021
1	Vasculitis (Vasculitides) 02/2021
1	Purpura 02/2021
1	Erythema elevatum diutinum 02/2021
1	Eczema 02/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021
1	Crohn Disease (Crohn's Disease) 02/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021

Drug/Important Bio-Agent (IBA)

14	Proton Pump InhibitorsIBA 01/2021 - 06/2007
12	AcidsIBA 01/2022 - 06/2007
10	Pharmaceutical PreparationsIBA 11/2022 - 12/2008
8	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021 - 05/2005
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2020 - 07/2004
4	CytokinesIBA 11/2017 - 10/2006
4	LigandsIBA 11/2017 - 11/2004
4	MucinsIBA 09/2011 - 08/2006
3	PotassiumIBA 01/2022 - 01/2016
3	Immunoglobulin G (IgG)IBA 06/2021 - 06/2019
3	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 06/2021 - 01/2018
3	Acetic Acid (Vinegar)FDA LinkGeneric 04/2020 - 04/2015
3	Chemokine CCL26IBA 01/2018 - 01/2016
3	AllergensIBA 01/2018 - 08/2013
3	Bile Acids and Salts (Bile Acids)IBA 03/2016 - 09/2011
3	Gentian Violet (Violet, Crystal)FDA Link 04/2015 - 01/2004
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2015 - 06/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013 - 04/2003
2	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2022 - 07/2021
2	ChemokinesIBA 01/2021 - 11/2017
2	Glutens (Glutelin)IBA 08/2020 - 02/2018
2	Z 338IBA 04/2018 - 09/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2018 - 10/2011
2	Interleukin-13IBA 01/2018 - 01/2016
2	Interleukin-5 (Interleukin 5)IBA 01/2018 - 01/2016
2	Interleukin-15 (Interleukin 15)IBA 01/2018 - 01/2016
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 11/2017 - 07/2011
2	Messenger RNA (mRNA)IBA 09/2011 - 07/2006
2	InterferonsIBA 01/2010 - 01/2003
2	Pattern Recognition ReceptorsIBA 01/2006 - 04/2003
2	Dextrans (Dextran)FDA Link 01/2006 - 04/2003
2	NF-kappa B (NF-kB)IBA 01/2006 - 01/2006
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2006 - 04/2003
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022
1	Immune Checkpoint InhibitorsIBA 05/2022
1	NivolumabIBA 05/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2022
1	SteroidsIBA 06/2021
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 03/2021
1	Sodium-Glucose Transport ProteinsIBA 03/2021
1	dapagliflozinIBA 03/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2021
1	Infliximab (Remicade)FDA Link 02/2021

Therapy/Procedure

12	Therapeutics 05/2022 - 01/2003
2	Lasers (Laser) 04/2022 - 10/2006
2	Endoscopes 03/2020 - 01/2018
1	Drug Therapy (Chemotherapy) 11/2022
1	Remission Induction 05/2022
1	Diet Therapy (Therapy, Diet) 07/2021